Abstrakt

Introduction: The incidence of Parkinson’s disease and the severity of accompanying motor impairment increase significantly with age. The etiopathogenesis and progression of Parkinson’s disease at the molecular level is associated with the production of cytokines and acute phase proteins, which are also typical for inflammatory diseases, such as periodontitis and gingivitis. Objectives: The aim of the study was to assess the correlation between neurological parameters, the indices of periodontal status and systemic parameters of inflammation, as well as their change after treatment. Patients/Methods: The presented study is a retrospective analysis of data obtained from medical histories and patient charts. Charts of 93 patients diagnosed with Parkinson’s disease and periodontal diseases over the period 2015–2017 were selected. Sixty-one of these patients received periodontal treatment: professional scaling, root planning – SRP and periodontal pockets rinsing with 3% H2O2 and constituted a study group. Additionally, the patients were instructed to use a 0.2% chlorhexidine mouthwash. The other 32 patients, who were not periodontally treated, formed a control group. Both groups continued their anti-parkinsonian treatment. Results: The mean pocket depth at the baseline was 4.0 mm (SD 0.9 mm), mean bleeding index was 56.2%, and 63.9% of patients presented tooth mobility grade II or III. A significant correlation between periodontal and neurological parameters was observed at the baseline. After periodontal treatment, an improvement of both periodontal parameters and those related to the Parkinson’s disease was observed in the study group. Those periodontally treated exhibited lower number of anti-parkinsonian medicines, lower number of falls, as well as better results in10-m walk test and timed-up-and-go test, as compared to the control group. The improvement was observed both 3 and 9 months after the end of treatment.

Przypisy

• 1. Almeida L.R., Valenca G.T., Oliveira-Filho J.: A MDS-UPDRS PartII (motor experiences of daily living) score to predict recurrentfalls in people with Parkinson’s disease. J. Neurol. Sci., 2017; 383:114–115
  Google Scholar
• 2. Ashburn A., Fazakarley L., Ballinger C., Pickering R., McLellanL.D., Fitton C.: A randomised controlled trial of a home basedexercise programme to reduce the risk of falling among peoplewith Parkinson’s disease. J. Neurol. Neurosurg. Psychiatry, 2007;78: 678–684
  Google Scholar
• 3. Ashburn A., Stack E., Pickering R.M., Ward C.D.: A communitydwellingsample of people with Parkinson’s disease: Characteristicsof fallers and non-fallers. Age Ageing, 2001; 30: 47–52
  Google Scholar
• 4. Beydoun H.A., Beydoun M.A., Mishra N.K., Rostant O.S., ZondermanA.B., Eid S.M.: Comorbid Parkinson’s disease, falls andfractures in the 2010 National Emergency Department Sample.Parkinsonism Relat. Disord., 2017; 35: 30–35
  Google Scholar
• 5. Bharathi Rao K.S.: Thermodynamics imprinting reveals differentialbinding of metals to α-synuclein: Relevance to Parkinson’sdisease. Biochem. Biophys. Res. Commun., 2007; 359: 115–120
  Google Scholar
• 6. Block V.A., Pitsch E., Tahir P., Cree B.A., Allen D.D., Gelfand J.M.:Remote physical activity monitoring in neurological disease: Asystematic review. PLoS One, 2016; 11: e0154335
  Google Scholar
• 7. Boereboom F.T., Raymakers J.A., Duursma S.A.: Mortality andcauses of death after hip fractures in the Netherlands. Neth. J.Med.,1992; 41: 4–10
  Google Scholar
• 8. Bower J.H., Maraganore D.M., McDonnell S.K., Rocca W.A.: Incidenceand distribution of parkinsonism in Olmsted County, Minnesota,1976–1990. Neurology, 1999; 52: 1214–1220
  Google Scholar
• 9. Camacho-Soto A., Warden M.N., Searles Nielsen S., Salter A.,Brody D.L., Prather H., Racette B.A.: Traumatic brain injury in theprodromal period of Parkinson’s disease: A large epidemiologicalstudy using medicare data. Ann. Neurol. 2017; 82: 744–754
  Google Scholar
• 10. Chapple I.L., Genco R., Working group 2 of the joint EFP/AAPworkshop: Diabetes and periodontal diseases: Consensus report ofthe Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases.J. Periodontol., 2013; 84: S106–S112
  Google Scholar
• 11. Chen C.K., Wu Y.T., Chang Y.C.: Periodontal inflammatory diseaseis associated with the risk of Parkinson’s disease: A population-based retrospective matched-cohort study. Peer J., 2017; 5:e3647
  Google Scholar
• 12. Clerici I., Ferrazzoli D., Maestri R., Bossio F., Zivi I., Canesi M.,Pezzoli G., Frazzitta G.: Rehabilitation in progressive supranuclearpalsy: Effectiveness of two multidisciplinary treatments. PLoS One,2017; 12: e0170927
  Google Scholar
• 13. Fleisher J.E., Shah K., Fitts W., Dahodwala N.A.: Associationsand implications of low health literacy in Parkinson’s disease. Mov.Disord. Clin. Pract., 2016; 3: 250–256
  Google Scholar
• 14. Genco R.J., Borgnakke W.S.: Risk factors for periodontal disease.Periodontol. 2000, 2013; 62: 59–94
  Google Scholar
• 15. Gnädinger M., Mellinghoff H.U., Kaelin-Lang A.: Parkinson’sdisease and the bones. Swiss Med. Wkly., 2011; 141: w13154
  Google Scholar
• 16. Hanaoka A., Kashihara K.: Increased frequencies of caries,periodontal disease and tooth loss in patients with Parkinson’sdisease. J. Clin. Neurosci., 2009; 16: 1279–1282
  Google Scholar
• 17. Herrera A.J., Castaño A., Venero J.L., Cano J., Machado A.: Thesingle intranigral injection of LPS as a new model for studyingthe selective effects of inflammatory reactions on dopaminergicsystem. Neurobiol. Dis., 2000; 7: 429–447
  Google Scholar
• 18. Herrera A.J., Tomás-Camardiel M., Venero J.L., Cano J., MachadoA.: Inflammatory process as a determinant factor for the degenerationof substantia nigra dopaminergic neurons. J. Neural.Transm., 2005; 112: 111–119
  Google Scholar
• 19. Jankovic J.: Parkinson’s disease: Clinical features and diagnosis.J. Neurol. Neurosurg. Psychiatry, 2008; 79: 368–376
  Google Scholar
• 20. Jørgensen T.S., Hansen A.H., Sahlberg M., Gislason G.H., Torp-Pedersen C., Andersson C., Holm E.: Falls and comorbidity: Thepathway to fractures. Scand. J. Public. Health, 2014; 42: 287–294
  Google Scholar
• 21. Kaltenboeck A., Johnson S.J., Davis M.R., Birnbaum H.G., CarrollC.A., Tarrants M.L., Siderowf A.D.: Direct costs and survival ofmedicare beneficiaries with early and advanced Parkinson’s disease.Parkinsonism Relat. Disord., 2012; 18: 321–326
  Google Scholar
• 22. Kamer A.R., Pirraglia E., Tsui W., Rusinek H., VallabhajosulaS., Mosconi L., Yi L., McHugh P., Craig R.G., Svetcov S., Linker R.,Shi C., Glodzik L., Williams S., Corby P., et al.: Periodontal diseaseassociates with higher brain amyloid load in normal elderly. Neurobiol.Aging, 2015; 36: 627–633
  Google Scholar
• 23. Kannus P., Parkkari J., Niemi S., Pasanen M., Palvanen M.,Järvinen M., Vuori I.: Prevention of hip fracture in elderly peoplewith use of a hip protector. N. Engl. J. Med., 2000; 343: 1506–1513
  Google Scholar
• 24. Kaur T., Uppoor A., Naik D.: Parkinson’s disease and periodontitis– the missing link? A review. Gerodontology, 2016; 33: 434–438
  Google Scholar
• 25. Koller W.C., Glatt S., Vetere-Overfield B., Hassanein R.: Fallsand Parkinson’s disease. Clin. Neuropharmacol., 1989; 12: 98–105
  Google Scholar
• 26. Lee B.D., Shin J.H., VanKampen J., Petrucelli L., West A.B., KoH.S., Lee Y.I., Maguire-Zeiss K.A., Bowers W.J., Federoff H.J., DawsonV.L., Dawson T.M.: Inhibitors of leucine-rich repeat kinase-2 protectagainst models of Parkinson’s disease. Nat. Med., 2010; 16: 998–1000
  Google Scholar
• 27. Ryu S.H., Jung H.Y., Lee K.J., Moon S.W., Lee D.W., Hong N., KeeB.S., Kim D.H., Han C., Lee C.U.: Incidence and course of depressionin patients with Alzheimer’s disease. Psychiatry Investig.,2017; 14: 271–280
  Google Scholar
• 28. Tarakad A., Jankovic J.: Diagnosis and management of Parkinson’sdisease. Semin. Neurol., 2017; 37: 118–126
  Google Scholar
• 29. Van Den Eeden S.K., Tanner C.M., Bernstein A.L., Fross R.D.,Leimpeter A., Bloch D.A., Nelson L.M.: Incidence of Parkinson’sdisease: Variation by age, gender, and race/ethnicity. Am. J. Epidemiol.,2003; 157: 1015–1022
  Google Scholar
• 30. von Renteln-Kruse W., Krause T.: Fall events in geriatric hospitalin-patients. Results of prospective recording over a 3 yearperiod. Z. Gerontol. Geriatr., 2004; 37: 9–14
  Google Scholar
• 31. Voss T.S., Elm J.J., Wielinski C.L., Aminoff M.J., BandyopadhyayD., Chou K.L., Sudarsky L.R., Tilley B.C., Falls Writing Group NINDSNET-PD Investigators: Fall frequency and risk assessment in earlyParkinson’s disease. Parkinsonism Relat. Disord., 2012; 18: 837–841
  Google Scholar
• 32. Wood B.H., Bilclough J.A., Bowron A., Walker R.W.: Incidenceand prediction of falls in Parkinson’s disease: A prospectivemultidisciplinary study. J. Neurol. Neurosurg. Psychiatry, 2002;72: 721–725
  Google Scholar

Pełna treść artykułu